Zobrazeno 1 - 6
of 6
pro vyhledávání: '"S M Vogen"'
Publikováno v:
The Journal of Immunology. 158:1670-1680
Site-directed polyclonal Abs specific for a synthetic peptide with sequence homology to the predicted N-terminal sequence of the human kappa opioid receptor [anti-kappa R-(33-52)] are capable of binding to normal human cells and cell lines expressing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29a573fd33c460942dc46338ac2ec367
https://doi.org/10.4049/jimmunol.158.4.1670
https://doi.org/10.4049/jimmunol.158.4.1670
Autor:
D P, Davis, G, Gallo, S M, Vogen, J L, Dul, K L, Sciarretta, A, Kumar, R, Raffen, F J, Stevens, Y, Argon
Publikováno v:
Journal of molecular biology. 313(5)
Deposition of monoclonal immunoglobulin light chain (LC) aggregates in tissues is the hallmark of a class of fatal diseases with no effective treatment. In the most prevalent diseases two different types of LC aggregates are observed: fibrillar depos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dea5cd40a1ec67cbadfacf782a8ff55c
https://pubmed.ncbi.nlm.nih.gov/11700059
https://pubmed.ncbi.nlm.nih.gov/11700059
Publikováno v:
British journal of pharmacology. 128(3)
Some in vivo activities of two complement C5a agonist analogues have been evaluated by measuring changes in blood pressure and neutropenia in the rat and comparing the results with their receptor affinities in peritoneal macrophages and polymorphonuc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17dc5c7c59b1c75ef8a8e41dfea1302a
https://pubmed.ncbi.nlm.nih.gov/10516626
https://pubmed.ncbi.nlm.nih.gov/10516626
Publikováno v:
The journal of peptide research : official journal of the American Peptide Society. 54(1)
The structural features related to the biologic activities of a potent, response-selective decapeptide agonist of human C5a, YSFKPMPLaR (C5a65-74, Y65, F67, P69, P71, D-Ala73), were identified by NMR analysis in H2O, DMSO and TFE. This investigation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fd671d1e773e9dbbbbedb16f47b8b7c6
https://pubmed.ncbi.nlm.nih.gov/10448972
https://pubmed.ncbi.nlm.nih.gov/10448972
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 158(4)
Site-directed polyclonal Abs specific for a synthetic peptide with sequence homology to the predicted N-terminal sequence of the human kappa opioid receptor [anti-kappa R-(33-52)] are capable of binding to normal human cells and cell lines expressing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4b82a43561216dd351ae6e53c48bb8fa
https://pubmed.ncbi.nlm.nih.gov/9029103
https://pubmed.ncbi.nlm.nih.gov/9029103
Autor:
R M, Tempero, M A, Hollingsworth, M D, Burdick, A M, Finch, S M, Taylor, S M, Vogen, E L, Morgan, S D, Sanderson
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 158(3)
A conformationally biased decapeptide agonist of human C5a anaphylatoxin (YSFKPMPLaR) was used as a molecular adjuvant in stimulating Ab responses against peptide epitopes derived from human MUC1 glycoprotein and the human mu and kappa opioid recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3fbd0e8bf03abd1ca7309563c56e063d
https://pubmed.ncbi.nlm.nih.gov/9013982
https://pubmed.ncbi.nlm.nih.gov/9013982